All lobbying filings
LEAVITT PARTNERS, LLC
Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Biopharmaceutical company.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
3
-
MELISSA PFAFFPreviously held: Senate HELP: Senior Health Policy Advisor-Ranking Member (RM); Senior Policy Advisor-Chair; Health Policy Advisor-Chair; Prof Staff Member-Chair; Prof Staff Member-RM; Prof Staff Member RM-Senate Budget; Leg Corres-Senate; Staff Assistant-Senate
-
CONNOR SHEEHEY New on this filingPreviously held: Senate Finance: Senior Health Policy Advisor-Chair; Senior Health Policy Advisor-RM; Health Policy Advisor-RM; Deputy Legislative Director-Senate; Legislative Assistant-Senate; Deputy Legislative Assistant-Senate; Legislative Fellow-Senate
-
JOSH TRENTPreviously held: Chief Health Counsel for Chairman - House E&C Committee (E&C); Deputy Chief Health Counsel - E&C; Professional Staff - E&C; Health Care Policy Advisor - Senate; Deputy Director Office of Refugee Resettlement HHS; WH Office of Presidential Personnel
Government bodies contacted
3
Lobbying activity
1
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).